| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.4 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |